Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Non-small-cell lung carcinoma | D002289 | — | — | 1 | 1 | — | — | — | 1 |
Lung neoplasms | D008175 | — | C34.90 | 1 | 1 | — | — | — | 1 |
Small cell lung carcinoma | D055752 | — | — | 1 | 1 | — | — | — | 1 |
Thoracic neoplasms | D013899 | — | — | 1 | 1 | — | — | — | 1 |
Thymoma | D013945 | — | — | 1 | 1 | — | — | — | 1 |
Thymus neoplasms | D013953 | — | C37 | 1 | 1 | — | — | — | 1 |
Drug common name | Vorolanib |
INN | vorolanib |
Description | Vorolanib is a small molecule pharmaceutical. It is currently being investigated in clinical studies. |
Classification | Small molecule |
Drug class | angiogenesis inhibitors |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)N[C@H]1CCN(C(=O)N(C)C)C1 |
PDB | — |
CAS-ID | 1013920-15-4 |
RxCUI | — |
ChEMBL ID | CHEMBL4297587 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | YP8G3I74EL (ChemIDplus, GSRS) |